Your science will
change lives.
Let's build the organization
to make it happen.

LED Consulting partners with biopharma organizations to transform operational capabilities, elevate your people, and align strategy, operations, and execution — accelerating performance, sustaining growth, and cultivating continuous improvement. Because when your organization performs at its peak, your science changes lives.

Start a conversation
LED Consulting, Inc.

30%

reduction in
forecast variance

25%

improvement in
milestone achievement

$450M+

in alliance value
directed

50%

reduction in
rework

About

Experience across every stage and scale of biopharma

LED Consulting, Inc. was founded by Linda Dickinson, a biopharma leader with 15+ years across global organizations including Merck, Johnson & Johnson, and Pfizer, alongside clinical-stage biotechs, from IND-enabling stages through commercialization.

From startups finding their footing to global enterprises under pressure to move faster, LED Consulting delivers the leadership that reduces cost, matures organizational capability, advances programs, and drives growth.

Linda Dickinson, Founder and Principal of LED Consulting, Inc.

Linda Dickinson · Founder & Principal

"Transformation is never change for its own sake — it starts with a clearly defined business need and measurable baseline, and ends with outcomes that prove the value."

What We Do

Good science needs an organization that can keep up

Every engagement starts with the specific need, gap, or opportunity, and ends with measurable outcomes the organization keeps building on.

Operational Transformation

Establishing the governance, processes, and operating discipline that make organizations run faster, leaner, and at lower cost, starting with root cause analysis to ensure the right problems are solved. Lean Six Sigma rigor and change management drive adoption and full value capture, not just implementation.

→ Cost reduction · Process efficiency · Sustained improvement

Alliance Management

Leading complex, multi-tier alliances across the full asset lifecycle, from early R&D through commercialization, establishing the governance, trust, and operational discipline that maximizes strategic and financial value, with metrics and measurement frameworks that bring objectivity and accountability to an inherently relationship-driven function.

→ JDC/JSC governance · Co-development & co-commercialization · Asset value

Digital Transformation & AI

Building the data visibility organizations make decisions from. Generative AI and digital tools applied across R&D, commercial, and supply to sharpen insight and accelerate decisions in regulated environments. AI in biopharma frequently stalls at pilot; the difference is the governance and enterprise-wide adoption that carry it into daily use, so your teams can focus on what matters most.

→ Data-driven decisions · Operational efficiency · Enterprise adoption

S&OP & Supply Planning

Establishing and expanding integrated Sales and Operations Planning frameworks that steady forecasting, balance demand and supply, and protect clinical and commercial continuity across global CDMOs and partners. Building the tools and governance to reconcile demand by product and dose level against manufacturing schedules, yields, and plan of record for drug product and devices.

→ Forecast accuracy · Supply continuity · Cost control

Program Leadership & Governance

→ Executive Oversight · Strategic Alignment · Risk Mitigation

Clinical Programs

→ Regulatory pathway alignment · Launch readiness · Program acceleration

Portfolio Management

→ Strategic resource optimization · Portfolio prioritization · Enterprise clarity

Regulatory Strategy & Submissions

→ On-time submissions · Global compliance · Risk mitigation

Case Study · Operational Transformation

Building a PMO framework where none existed

Situation

A clinical-stage biopharma had grown faster than its operating model. There was no PMO or governance framework, no cross-functional alignment, and no transparency into where programs actually stood. Milestones slipped without anyone seeing them coming, and leadership was making capital and prioritization decisions on incomplete information.

Approach

Assessed how work was moving before designing anything, and where decisions were getting stuck. Built the governance model, planning standards, processes, and tooling. Established integrated program plans that aligned functions around a single view. Piloted on one program, refined against the results, then scaled with structured change management and training.

Outcome

Leadership had visibility into program status and the structure to act on it, with capital and prioritization decisions made against a clear view of the portfolio. Milestone achievement improved 25%, reducing cost and improving efficiency. The framework was adopted as the enterprise standard and supported the organization's growth.

How We Engage

Flexible models for every need

LED Consulting partners through a range of engagement models, from targeted consulting to fractional, interim, and advisory roles, through to full-time leadership. Reach out to explore what works best for your organization.

Let's Connect

Ready to tackle your most complex initiatives and elevate your organization?

ld@ledcon.com 610.716.0306 LinkedIn